Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5814280 | Neuropharmacology | 2015 | 10 Pages |
Abstract
In early Alzheimer's disease (AD) brain, reduction of sigma-1 receptors (Ï1R) is detected. In this study, we employed male heterozygous Ï1R knockout (Ï1R+/-) mice showing normal cognitive performance to investigate association of Ï1R deficiency with AD risk. Herein we report that a single injection (i.c.v.) of Aβ25-35 impaired spatial memory with approximately 25% death of pyramidal cells in the hippocampal CA1 region of WT mice (Aβ25-35-WT mice), whereas it did not cause such impairments in Ï1R+/- mice (Aβ25-35-Ï1R+/- mice). Compared with WT mice, Aβ25-35-WT mice showed increased levels of NMDA-activated currents (INMDA) and NR2B phosphorylation (phospho-NR2B) in the hippocampal CA1 region at 48 h after Aβ25-35-injection (post-Aβ25-35) followed by approximately 40% decline at 72 h post-Aβ25-35 of their respective control levels, which was inhibited by the Ï1R antagonist NE100. In Aβ25-35-WT mice, the administration of NR2B inhibitor Ro25-6981 or NE100 on day 1-4 post-Aβ25-35 attenuated the memory deficits and loss of pyramidal cells. By contrast, Aβ25-35-Ï1R+/- mice showed a slight increase in the INMDA density and the phospho-NR2B at 48 h or 72 h post-Aβ25-35 compared to Ï1R+/- mice. Treatment with Ï1R agonist PRE084 in Aβ25-35-Ï1R+/- mice caused the same changes in the INMDA density and the phospho-NR2B as those in Aβ25-35-WT mice. Furthermore, Aβ25-35-Ï1R+/- mice treated with the NMDA receptor agonist NMDA or PRE084 on day 1-4 post-Aβ25-35 showed a loss of neuronal cells and memory impairment. These results indicate that the Ï1R deficiency can reduce Aβ25-35-induced neuronal cell death and cognitive deficits through suppressing Aβ25-35-enhanced NR2B phosphorylation.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Jun Yin, Sha Sha, Tingting Chen, Conghui Wang, Juan Hong, Pinghui Jie, Rong Zhou, Lin Li, Masahiro Sokabe, Ling Chen,